Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial Emulation.
- DOI
- 10.1016/j.jtct.2026.09.046
- Published
- 2026 Sep 26
- Container
- Transplantation and cellular therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2026.09.046,
title = {Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial Emulation.},
author = {Zuber M and Tan CJ and Caballero J and Somanath PR and Godara A and Elshafie S and Zapata LV},
year = {2026},
journal = {Transplantation and cellular therapy},
doi = {10.1016/j.jtct.2026.09.046},
url = {https://doi.org/10.1016/j.jtct.2026.09.046}
}RIS
TY - JOUR TI - Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial Emulation. AU - Zuber M AU - Tan CJ AU - Caballero J AU - Somanath PR AU - Godara A AU - Elshafie S AU - Zapata LV PY - 2026 JO - Transplantation and cellular therapy DO - 10.1016/j.jtct.2026.09.046 UR - https://doi.org/10.1016/j.jtct.2026.09.046 ER -
APA
M, Z., CJ, T., J, C., PR, S., A, G., S, E., & LV, Z. (2026). Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial Emulation.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.09.046
Source records
- pubmed · retrieved 2026-09-27T11:02:07.011Z